Research Updates

NEAT Study – Phase 3 Clinical Trial of EryDex, a Low-Dose Steroid

Apr 22, 2024 Comments Off on NEAT Study – Phase 3 Clinical Trial of EryDex, a Low-Dose Steroid
May 23 @ 9:35 pm

Quince Therapeutics is advancing a phase 3 clinical trial to evaluate EryDex, a potential new treatment for ataxia-telangiectasia (A-T).

More

A-T Biomarker Development Initiative Now Recruiting

Dec 18, 2023 Comments Off on A-T Biomarker Development Initiative Now Recruiting
May 23 @ 9:35 pm

On December 18, the A-T Children’s Project sent out the below email to A-T parents in the United States inviting their children with and without A-T to participate in the A-T Biomarker Development Initiative. THE A-T BIOMARKER DEVELOPMENT INITIATIVE Join us in identifying desperately needed biomarkers to improve the development…

More

Giving Tuesday Update 2023

Nov 28, 2023 Comments Off on Giving Tuesday Update 2023
May 23 @ 9:35 pm

It’s Giving Tuesday, and anonymous donors have joined together to match the first $60,000 in donations we receive! Please donate today to take advantage of this match and to help us keep our momentum as we head into 2024.

More

Exon Skipping for A-T – Funding Available

Aug 25, 2023 Comments Off on Exon Skipping for A-T – Funding Available
May 23 @ 9:35 pm

On August 25, the A-T Children’s Project sent the below email to A-T researchers about available funds for a grant to see if exon skipping would make sense as a therapeutic approach for A-T. Dear A-T Researchers, We wanted to let you know of a funding opportunity through a partnership…

More

Groundbreaking Study Reports Significant Milestone for A-T Research

Jul 18, 2023 Comments Off on Groundbreaking Study Reports Significant Milestone for A-T Research
May 23 @ 9:35 pm

Timothy Yu, MD, PhD and his team at Boston Children’s Hospital just published a groundbreaking study in the prestigious science journal Nature, reporting a significant milestone for A-T research. The team analyzed the whole genome sequences of 235 individuals with A-T from the Global A-T Family Data Platform, creating an…

More

Testing a Treatment for A-T Patients with Dystonia

Jun 20, 2023 Comments Off on Testing a Treatment for A-T Patients with Dystonia
May 23 @ 9:35 pm

Researchers would like to test a new non-surgical, non-invasive way to stimulate specific regions of the brain using ultrasound waves to see if it can help people with A-T who have dystonia.

More

Adrestia Therapeutics Partners with Patient Advocacy Groups to Further A-T Research

Feb 8, 2023 Comments Off on Adrestia Therapeutics Partners with Patient Advocacy Groups to Further A-T Research
May 23 @ 9:35 pm

The A-T Children’s Project is excited to be part of this A-T research initiative. Please see the following press release from Adrestia Therapeutics:

More

Giving Tuesday 2022

Nov 29, 2022 Comments Off on Giving Tuesday 2022
May 23 @ 9:35 pm
More

Drug Repurposing Screen for A-T Reaches Important Milestone

Aug 11, 2022 Comments Off on Drug Repurposing Screen for A-T Reaches Important Milestone
May 23 @ 9:35 pm

Charles River Lab, a drug development services company collaborating with the A-T Children’s Project, has succeeded in developing a laboratory test or “assay” to rapidly evaluate thousands of approved drugs to learn if some of them can be repurposed for A-T. Because drugs emerging from the screening process with promising…

More

Promising Study Finds Ways to Measure A-T

Apr 14, 2022 Comments Off on Promising Study Finds Ways to Measure A-T
May 23 @ 9:35 pm

Dear Friends, We are excited to share the following update from Dr. Anoopum Gupta to the A-T families who have been participating in his project to find better ways to measure A-T. We are so grateful to him, to the families, and, of course, to our donors and fundraisers who…

More